Chemoinformaics analysis of N-Isobutyl-2,4,8-decatrienamide
| Molecular Weight | 221.344 | nRot | 7 |
| Heavy Atom Molecular Weight | 198.16 | nRig | 4 |
| Exact Molecular Weight | 221.178 | nRing | 0 |
| Solubility: LogS | -2.71 | nHRing | 0 |
| Solubility: LogP | 3.149 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.6182 |
| nHD | 1 | BPOL | 24.5118 |
| QED | 0.519 |
| Synth | 3.001 |
| Natural Product Likeliness | 1.029 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.413 |
| MDCK | 0.0000341 |
| BBB | 0.734 |
| PPB | 0.911741 |
| VDSS | 1.314 |
| FU | 0.084629 |
| CYP1A2-inh | 0.64 |
| CYP1A2-sub | 0.12 |
| CYP2c19-inh | 0.535 |
| CYP2c19-sub | 0.639 |
| CYP2c9-inh | 0.27 |
| CYP2c9-sub | 0.692 |
| CYP2d6-inh | 0.057 |
| CYP2d6-sub | 0.603 |
| CYP3a4-inh | 0.234 |
| CYP3a4-sub | 0.21 |
| CL | 11.55 |
| T12 | 0.834 |
| hERG | 0.041 |
| Ames | 0.295 |
| ROA | 0.604 |
| SkinSen | 0.964 |
| Carcinogencity | 0.67 |
| EI | 0.763 |
| Respiratory | 0.877 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.752427 |